|
As the lot number for the device was provided, a review of the device history records is currently being performed.The device has not been returned to the manufacturer for evaluation.However, an image was provided for review.The investigation of the reported event is currently underway.(expiration date: 02/2024).Device not returned.
|
|
H10: manufacturing review: the lot history records of this lot were reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.Based on the information available it is not reasonably suggested that a manufacturing process may have caused or contributed to the reported issue.Investigation summary: the catheter sample is not available for evaluation.Provided image demonstrates a mid-section of the stent.Deformation is visible but due to poor resolution a more detailed strut evaluation is not possible.A stent fracture or twist could not be confirmed.The vessel was tortuous/ calcified, the lesion was pre dilated, and the user did not experience difficulty during deployment.The system was correctly held at the stability sheath, and torque was neither felt nor exerted.Based on the investigation of the provided information, the investigation is closed as confirmed for stent deformation.A definite root cause for the reported event could not be determined.Placement in the iliac artery represents an off label use of the device.Labeling review: in reviewing the relevant labeling for this product, the potential issue was found addressed.The instruction for use state: 'gain femoral access at the appropriate site using a 6f (2.0 mm) or larger introducer sheath.Insert a 0.035¿ diameter guidewire (.)', and 'predilation of the lesion should be performed using standard techniques.' holding and handling of the system was found sufficiently described, in particular the instruction for use state: 'remove slack from the stent system held outside the patient.', and 'to ensure the most accurate placement, firmly hold the black system stability sheath throughout deployment.' the lifestent xl vascular stent system is intended to improve luminal diameter in the treatment of symptomatic de novo or restenotic lesions up to 240 mm in length in the native superficial femoral artery (sfa) and popliteal artery with reference vessel diameters ranging from 4.0 - 6.5 mm.H10: b5, d4 (expiration date: 02/2024), g3, h6 (device) h11: h6 (method, result, conclusion) h11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|